Your search returned 2 results.

Results
	1.	FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer. [electronic resource] by Shah, Anand Bloomquist, Erik Tang, Shenghui Fu, Wentao Bi, Youwei Liu, Qi Yu, Jingyu Zhao, Ping Palmby, Todd R Goldberg, Kirsten B Chang, C J George Patel, Paresma Alebachew, Elleni Tilley, Amy Pierce, William F Ibrahim, Amna Blumenthal, Gideon M Sridhara, Rajeshwari Beaver, Julia A Pazdur, Richard Producer: 20191119 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia. [electronic resource] by de Claro, R Angelo McGinn, Karen M Verdun, Nicole Lee, Shwu-Luan Chiu, Haw-Jyh Saber, Haleh Brower, Margaret E Chang, C J George Pfuma, Elimika Habtemariam, Bahru Bullock, Julie Wang, Yun Nie, Lei Chen, Xiao-Hong Lu, Donghao Robert Al-Hakim, Ali Kane, Robert C Kaminskas, Edvardas Justice, Robert Farrell, Ann T Pazdur, Richard Producer: 20160614 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)